SBFM News and Press, Sunshine Biopharma Inc. From 02/13/24

NEW YORK, NY / ACCESSWIRE / February 13, 2024 / Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, today announced the pricing of a firm commitment un...

2024-02-01 16:37:24 ET More on Sunshine Biopharma Seeking Alpha’s Quant Rating on Sunshine Biopharma Historical earnings data for Sunshine Biopharma Financial information for Sunshine Biopharma Read the full article on Seeking Alpha For further...

NEW YORK, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: “SBFM”) (the “Company”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it ha...

2023-11-13 17:42:59 ET More on Sunshine Biopharma Seeking Alpha’s Quant Rating on Sunshine Biopharma Historical earnings data for Sunshine Biopharma Financial information for Sunshine Biopharma For further details see: Sunshine Biopharma GAAP EPS o...

MONTREAL, QC / ACCESSWIRE / November 13, 2023 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has filed its quarterly repor...

INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...

CGG ADR (CGGYY) is expected to report for quarter end 2023-09-30 ATI Physical Therapy Inc. Class A (ATIP) is expected to report $-4.08 for Q3 2023 Riot Platforms Inc. (RIOT) is expected to report $-0.29 for Q3 2023 Bain Capital Specialty Finance Inc. (BCSF) is expected to report $0.57...

Sunshine Biopharma Inc. (SBFM) is expected to report for Q1 2024

2023-09-22 04:39:23 ET More on QuantumKore Inc. Financial information for QuantumKore Inc. For further details see: Sunshine Biopharma gets 180-day extension to achieve Nasdaq compliance

2023-08-29 07:29:32 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s time for another dive into the biggest pre-market stock movers as we check out the shares worth watching on Tuesday! Moving shares are company mergers, bankruptcy news, a new co...